Inicio > cancer > Pfizer breast cancer drug fails late-stage test Pfizer breast cancer drug fails late-stage test By Excelsio Media on October 09, 2020 Also in cancer, health, Pfizer Pfizer says its cancer drug Ibrance did not meet the main goal in a late-stage trial in patients with a type of breast cancer. Share: Facebook X Reddit WhatsApp Email You Might Also Like ❮ ❯ Previous Next Cargando anterior... Cargando siguiente... Blogger Facebook Comments Comentarios de Facebook
Inicio > cancer > Pfizer breast cancer drug fails late-stage test Pfizer breast cancer drug fails late-stage test By Excelsio Media on October 09, 2020 Also in cancer, health, Pfizer Pfizer says its cancer drug Ibrance did not meet the main goal in a late-stage trial in patients with a type of breast cancer. Share: Facebook X Reddit WhatsApp Email You Might Also Like ❮ ❯ Previous Next Cargando anterior... Cargando siguiente... Blogger Facebook Comments Comentarios de Facebook
Comments
Post a Comment
Leave a comment. Thanks!
Comentarios de Facebook